Clinical Trials in Maryland

Showing 6561-6580 of 17,687 trials

Streamlined Genetic Testing in Prostate Cancer

NCT04359758

The goal of this pilot randomized controlled trial is to evaluate the impact and efficacy of a streamlined genetic education and testing intervention for men with prostate cancer. Eligible men are prostate cancer survivors who meet criteria for genetic counseling referral. After completing a baseline survey, participants (n=120) are randomized to Streamlined Genetic Testing (ST) or Usual Care (UC). Participants in ST are able to review genetic education materials and then proceed directly to genetic testing. Participants in UC will be provided with a referral for standard individual genetic counseling. Two months after randomization all participants will be contacted to complete a follow-up survey.

Prostate Cancer

Georgetown University112 participantsStarted Mar 2020

Washington D.C., District of Columbia, United States

COMPLETED17 miles

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

NCT05312177

The study objective is to compare neurodevelopmental (ND) and behavioral outcomes between children with Down syndrome (DS) who had complete atrioventricular septal defect (CAVSD) repair and children from the same clinical sites with DS without major congenital heart disease (CHD) requiring previous or planned CHD surgery.

Down SyndromeCongenital Heart Disease

Carelon Research273 participantsStarted May 2022

Wilmington, Delaware, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +11 more locations

Streamlined Genetic Testing in Prostate Cancer

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Find Trials by Condition in Maryland

B0151005 Open-Label Extension Study

Study of Probable Benefit of the Neuro-Spinal Scaffold™ in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care

Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

A Study of PTC923 in Participants With Phenylketonuria

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Study Evaluating Betrixaban in Pediatric Participants

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer

Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)